Profile | GDS4284 / 209706_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 370.51 | 60 |
GSM687648 | Patient 402 control | 831.948 | 71 |
GSM687653 | Patient 403 control | 353.437 | 59 |
GSM687658 | Patient 404 control | 336.314 | 57 |
GSM687663 | Patient 411 control | 442.353 | 61 |
GSM687668 | Patient 422 control | 532.604 | 65 |
GSM687673 | Patient 424 control | 152.777 | 42 |
GSM687678 | Patient 425 control | 875.245 | 71 |
GSM687683 | Patient 427 control | 265.079 | 52 |
GSM687688 | Patient 428 control | 260.18 | 53 |
GSM687695 | Patient 441 control | 81.9016 | 22 |
GSM687699 | Patient 443 control | 544.993 | 64 |
GSM687704 | Patient 444 control | 784.744 | 70 |
GSM687707 | Patient 448 control | 526.121 | 64 |
GSM687712 | Patient 449 control | 290.743 | 55 |
GSM687719 | Patient 450 control | 471.318 | 61 |
GSM687724 | Patient 451 control | 291.522 | 54 |
GSM687728 | Patient 452 control | 460.628 | 63 |
GSM687646 | Patient 401 treated 24h | 395.426 | 59 |
GSM687649 | Patient 402 treated 24h | 674.196 | 68 |
GSM687665 | Patient 411 treated 24h | 346.184 | 57 |
GSM687651 | Patient 402 treated 4 weeks | 806.031 | 70 |
GSM687667 | Patient 411 treated 4 weeks | 483.73 | 63 |
GSM687670 | Patient 422 treated 24h | 575.437 | 65 |
GSM687671 | Patient 422 treated 4 weeks | 553.494 | 65 |
GSM687654 | Patient 403 treated 24h | 469.321 | 63 |
GSM687675 | Patient 424 treated 24h | 164.576 | 42 |
GSM687685 | Patient 427 treated 24h | 323.764 | 56 |
GSM687656 | Patient 403 treated 4 weeks | 279.534 | 56 |
GSM687677 | Patient 424 treated 4 weeks | 214.539 | 50 |
GSM687687 | Patient 427 treated 4 weeks | 337.203 | 58 |
GSM687692 | Patient 428 treated 4h | 131.395 | 40 |
GSM687716 | Patient 449 treated 4h | 359.92 | 59 |
GSM687722 | Patient 450 treated 4h | 501.526 | 63 |
GSM687680 | Patient 425 treated 24h | 947.289 | 73 |
GSM687690 | Patient 428 treated 24h | 300.454 | 57 |
GSM687700 | Patient 443 treated 24h | 409.083 | 57 |
GSM687705 | Patient 444 treated 24h | 933.746 | 73 |
GSM687714 | Patient 449 treated 24h | 290.981 | 56 |
GSM687721 | Patient 450 treated 24h | 614.047 | 66 |
GSM687682 | Patient 425 treated 4 weeks | 919.339 | 73 |
GSM687694 | Patient 428 treated 4 weeks | 216.196 | 51 |
GSM687702 | Patient 443 treated 4 weeks | 254.407 | 50 |
GSM687718 | Patient 449 treated 4 weeks | 452.505 | 62 |
GSM687723 | Patient 450 treated 4 weeks | 600.275 | 66 |
GSM687661 | Patient 404 treated 4h | 392.329 | 59 |
GSM687710 | Patient 448 treated 4h | 485.827 | 64 |
GSM687726 | Patient 451 treated 4h | 193.473 | 45 |
GSM687730 | Patient 452 treated 4h | 546.159 | 58 |
GSM687660 | Patient 404 treated 24h | 389.354 | 59 |
GSM687697 | Patient 441 treated 24h | 329.829 | 53 |
GSM687709 | Patient 448 treated 24h | 611.599 | 67 |
GSM687725 | Patient 451 treated 24h | 345.493 | 56 |
GSM687729 | Patient 452 treated 24h | 278.988 | 50 |
GSM687727 | Patient 451 treated 4 weeks | 198.828 | 45 |
GSM687731 | Patient 452 treated 4 weeks | 445.214 | 61 |